INTRODUCTION {#S1}
============

In the developing spinal cord, bone morphogenic proteins (BMPs) from the roof plate and Sonic hedgehog (Shh) from the floor plate form opposing gradients of activity that are essential to specify neurons ([@R16]; [@R32]). Commissural neurons reside in the dorsal spinal cord and send axons ventrally. This is due to BMPs inducing repulsion through non-canonical signaling ([@R3]; [@R7]). In addition, netrin1, produced by the ventricular zone and enriched along the pial edge in the dorsal spinal cord, confines axons to the periphery of the spinal cord ([@R14]; [@R51]). Subsequently, netrin1, Shh, and VEGF, produced by floor plate cells, cooperate to attract commissural axons at a distance and guide them to the ventral midline ([@R10]; [@R26]; [@R37]; [@R43]; [@R45]; [@R46]; [@R53]).

Importantly, Shh is reused at multiple steps of neural development ([@R55]), including neural cell fate specification and axon guidance. Ventral neural cell fates are determined by a gradient of Shh activity, which is converted to a transcriptional response by the Gli family of transcription factors ([@R6]; [@R47]); this is referred to as the canonical Shh signaling pathway. In contrast, axon guidance by Shh occurs through a non-canonical transcription-independent pathway and relies on actin cytoskeleton remodeling at the growth cone ([@R31]; [@R35]; [@R56], [@R57]).

Canonical Shh signaling is intimately linked to the primary cilium, a microtubule projection at the cell surface ([@R2]; [@R20]; [@R25]). Dynamic enrichment of Shh signaling components within cilia is critical both to activate Smoothened (Smo) and to process the Gli transcription factors that mediate the pathway's transcriptional response ([@R12]; [@R22]; [@R24]). Although axons are also microtubule-based cellular projections, the relationship between Shh signaling, the primary cilium, and axon guidance remains unexplored.

Joubert syndrome, a disease caused by mutations in more than 35 different cilia-associated genes, is diagnosed by the presence of a hindbrain malformation known as the molar tooth sign, a combination of the superior cerebellar peduncles failing to cross the midline of the brain and a hypoplastic cerebellum ([@R1]; [@R13]; [@R29]; [@R50]; [@R54]). The patients also display abnormal pyramidal decussation and impaired crossing of the optic chiasm. Thus, Joubert syndrome patients exhibit defects in axon guidance although the mechanism underlying these defects is not known. One of the genes associated with Joubert syndrome is *ARL13B*, whose mouse ortholog *Arl13b* encodes a small GTPase highly enriched in cilia and that regulates canonical Shh signal transduction ([@R8]; [@R9]; [@R41]; [@R49]).

Although the mechanism of Arl13b is still unknown, Arl proteins are well established for their roles in trafficking. In the absence of Arl13b function, several components of Shh signaling are abnormally trafficked within cilia ([@R28]). In normal conditions, in the absence of Shh ligand, Patched1 (Ptch1) is present at the ciliary membrane and the Gli proteins traffic in and out of the cilium, where they are cleaved to transcriptional repressors that shuttle to the nucleus ([@R22]; [@R24]; [@R34]; [@R42]). When Shh binds Ptch1, Ptch1 exits the cilium, and Smo becomes enriched at the cilium ([@R12]; [@R42]). The presence of activated Smo in the cilium leads to accumulation of Gli proteins at the tip of the cilium, inhibits Gli repressor (GliR) formation, and triggers the formation of Gli activator (GliA). In *Arl13b^hnn/hnn^* mutant mouse embryos, cilia are short and the normal trafficking of Shh components to cilia is lost: Ptch1 and Smo are located in cilia regardless of the presence of Shh ligand, and there is no ligand-dependent Gli enrichment at the ciliary tip. The consequence is that GliR production is normal, and there is low-level constitutive activation of the Shh transcriptional response ([@R9]; [@R28]).

In non-canonical Shh signaling, Shh guides axons by binding its receptor Boc, and possibly Ptch1, which localize to the growth cone ([@R18]; [@R39]). This elicits two parallel downstream signaling activities: one that activates Smo, which in turn activates Src family kinases (SFKs) and initiates a cascade resulting in local β-actin protein synthesis, and another signaling activity that leads to the polarized activation of cytoskeletal actin remodeling proteins ([@R31]; [@R35]; [@R56]). These two processes, acting locally in the growth cone, result in growth cone turning toward Shh.

Given the role of Arl13b in canonical Shh signaling, we investigated whether Arl13b also plays a role in Shh-mediated axon guidance. Here we report abnormal commissural axon trajectory in embryos lacking Arl13b function. Despite abnormal neural patterning in **Arl13b** mutants, we show that mispatterning does not cause the abnormal commissural axon trajectory that we observe in *Arl13b* mutants, suggesting that Arl13b may act cell autonomously in axon guidance. Indeed, through *in vitro* turning assays, we demonstrate that Arl13b is required for commissural axon turning in response to Shh, indicating that Arl13b functions autonomously in commissural neurons, where it localizes to the growth cone. We further show that a cilia localization-deficient variant of Arl13b is sufficient to mediate axon turning toward Shh *in vitro*. *In vivo*, we show that knockin mice expressing a cilia localization-deficient Arl13b display normal commissural axon guidance. Together, these results establish that, in addition to its well-established ciliary role in canonical Shh signaling, Arl13b also has a cilia-independent role in Shh-mediated axon guidance.

RESULTS {#S2}
=======

Abnormal Commissural Axon Projections and Midline Crossing in *Arl13^hnn/hnn^* Spinal Cord {#S3}
------------------------------------------------------------------------------------------

To test whether Arl13b plays a role in commissural axon guidance, we analyzed embryonic day (E)11.5 *Arl13^hnn/hnn^* (null) spinal cords using an antibody against Robo3. Robo3 marks commissural neurons from their cell bodies in the dorsal spinal cord through their axons projecting toward the floor plate and across the midline ([@R44]). As is routinely done to assess spinal commissural axon guidance, we performed our analysis on rostral sections, at the forelimb level. In E11.5 wild-type sections, commissural axons migrate along the periphery of the spinal cord until they reach the motor column ([Figure 1A](#F1){ref-type="fig"}). At the motor column, commissural axons break away and dive toward the ventral midline, largely avoiding the motor column ([Figure 1A](#F1){ref-type="fig"}). In *Arl13b^hnn/hnn^* spinal cords, commissural axons migrate normally along the periphery of the spinal cord; however, upon reaching the motor column, many axons invade the motor column, and only a subset of axons reach the ventral midline ([Figure 1B](#F1){ref-type="fig"}). We quantified the disorganization of Robo3+ axons in *Arl13b^hnn/hnn^* ventral spinal cords by measuring the area of Robo3 staining relative to the total ventral area. *Arl13b^hnn/hnn^* ventral spinal cords displayed a significant increase in the area occupied by Robo3+ axons compared to wild-type littermate controls ([Figure 1C](#F1){ref-type="fig"}). Thus, *Arl13b^hnn/hnn^* spinal cords display abnormal commissural axon projections and midline crossing.

Several mouse mutants of ciliary genes exhibit different degrees of severity of spinal cord mispatterning depending on axial position, with most showing profound defects in caudal neural tube patterning and normal or only slightly defective patterning of the rostral neural tube ([@R9]; [@R15]; [@R24]; [@R33]). Arl13b regulates Shh signaling during neural tube patterning, and *Arl13b^hnn/hnn^* mutants have highly reduced levels of Shh in the caudal neural tube ([@R9]), raising the possibility that the abnormal commissural axon projections in the *Arl13b^hnn/hnn^* rostral spinal cord may be due to abnormal expression of Shh. To examine this, we stained rostral sections (i.e., at the same position where we analyzed Robo3+ axons) and caudal sections using an antibody against Shh. As expected in caudal sections, we detected Shh expression in the floor plate of control but significantly less in *Arl13b^hnn/hnn^* sections ([Figures 1D](#F1){ref-type="fig"} and [1E](#F1){ref-type="fig"}). In contrast, in rostral sections, we found normal Shh expression in the floor plate of both wild-type and *Arl13b^hnn/hnn^* embryos. Together, these data suggest that the defect in axon guidance in *Arl13b^hnn/hnn^* mutants is not due to abnormal expression of Shh in the floor plate. All subsequent analyses in this study were performed on rostral neural tube sections.

We next verified if the number of commissural neurons generated in *Arl13b^hnn/hnn^* mutants is normal. For this, we quantified the number of Lhx2+ neurons (a marker of dI1 neurons and a transcription factor controlling directly *Robo3* expression) ([@R52]). The number of Lhx2+ neurons in *Arl13b^hnn/hnn^* mutants was not significantly different from controls ([Figures S1A](#SD1){ref-type="supplementary-material"} and [S1B](#SD1){ref-type="supplementary-material"}).

Neural Tube Mispatterning Does Not Cause the Abnormal Commissural Axon Trajectory Observed *Arl13b* Mutants {#S4}
-----------------------------------------------------------------------------------------------------------

The commissural axon phenotype observed in *Arl13b^hnn/hnn^* spinal cords could be due to a cell-autonomous role of Arl13b in commissural neurons or a non-cell-autonomous role of Arl13b in patterning the neural tube. Indeed, the motor column of embryos lacking Arl13b is expanded, reflecting a patterning defect ([@R9]). Thus, to explore the possibility that the abnormal trajectory of commissural axons could be secondary to a patterning defect, we examined commissural axon guidance in Tubby-like protein 3 (Tulp3)-deficient embryos, which also display abnormal motor neuron patterning ([@R30]; [@R38]). Similar to Arl13b, Tulp3 is a cilia protein known to regulate Shh signaling and neural tube patterning. To determine whether Arl13b is expressed normally in the *Tulp3* mutant neural tube, we first analyzed forelimb-level E11.5 *Tulp3*^−/−^ (null) spinal cord sections with an Arl13b antibody. Using IFT88 as a cilium marker, we found that Arl13b localized normally to primary cilium in control and *Tulp3*−/− embryos ([Figure 2A](#F2){ref-type="fig"}).

We next investigated whether Lhx2+ neurons are generated normally in *Tulp3* mutants. We observed that the number of Lhx2+ neurons in *Tulp3* mutants was not significantly different from controls ([Figures S1C](#SD1){ref-type="supplementary-material"} and [S1D](#SD1){ref-type="supplementary-material"}), indicating a normal patterning of commissural neurons in *Tulp3* mutants.

Following this, we investigated commissural axon trajectory in *Tulp3* mutants using an antibody against Robo3. In *Tulp3*^−/−^ spinal cords, compared to wild-type spinal cords, we observed that commissural axons projected normally for most of their trajectory, until they came in close proximity to the floor plate, where we observed a small defasciculation of the axons ([Figure 2B](#F2){ref-type="fig"}, arrows). Despite this small defasciculation, we found no difference when we measured the area of Robo3 staining relative to the total ventral area in wild-type and *Tulp3*^−/−^ sections ([Figure 2C](#F2){ref-type="fig"}). Thus, despite abnormal ventral neural patterning resembling *Arl13b* mutants, mispatterning on its own does not cause the abnormal motor column invasion by commissural axon that we observe in *Arl13b* mutants, suggesting that the commissural axon guidance defect observed in *Arl13b* mutants is unlikely to be due to a non-cell-autonomous role of Arl13b.

To further support these results, we next analyzed *Kif7* mutants for commissural axon guidance defects. *Kif7* mutants, analogously to *Arl13b* and *Tulp3* mutants, show an expansion of the motor column ([@R11]). Robo3 immunostaining revealed that *Kif7* mutants did not show commissural axon guidance defects ([Figures 2D](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). The absence of commissural axon guidance defects in *Kif7* mutants reinforces our *Tulp3* mutant results indicating that ventral cell fate mispatterning is not sufficient to cause the axon guidance defects observed in *Arl13b* mutants, supporting the idea that Arl13b functions in a cell-autonomous manner *in vivo* for commissural axon guidance.

Arl13b Is Required for Shh-Mediated Growth Cone Turning {#S5}
-------------------------------------------------------

Because the experiments above suggest that the role of Arl13b in commissural axons guidance is unlikely to be due to a non-cell-autonomous role in spinal cord patterning, we explored the possibility that Arl13 functions cell autonomously in the guidance of commissural neurons. Since Arl13b plays a role in canonical Shh signaling, we hypothesized that it might also play a role in Shh-signaling-mediated axon guidance of commissural axons. To test this, we first assessed the expression of Arl13b in commissural neurons. Using commissural neurons isolated from E13.5 rat spinal cords, we performed RNA sequencing (RNA-seq) and immunostaining. RNA-seq showed significant expression of *Arl13b* in commissural neurons, similar to the levels of *Boc* and *Smo* ([Figure 3A](#F3){ref-type="fig"}). Immunostaining on commissural neurons cultured *in vitro* showed that Arl13b localizes to the primary cilium of commissural neurons, which is located at the cell body ([Figure 3B](#F3){ref-type="fig"}). In addition, we detected a faint but reproducible amount of Arl13b present at the axon and the growth cone of commissural neurons. To confirm that this growth cone staining is indeed due to Arl13b, we electroporated commissural neurons with a short hairpin RNA (shRNA) against Arl13b (shArl13b) or a scrambled control and then performed Arl13b immunostaining. As expected, shArl13b significantly reduced the number of cilia that are Arl13b+ ([Figures 3C](#F3){ref-type="fig"} and [3D](#F3){ref-type="fig"}). In addition, shArl13b significantly reduced growth cone Arl13b staining ([Figures 3E](#F3){ref-type="fig"} and [3F](#F3){ref-type="fig"}), confirming the specificity of our growth cone Arl13b immunostaining. Thus, in addition to its ciliary localization, Arl13b is a bona fide growth cone protein.

Next, to assess whether Arl13b plays a role in Shh-mediated axon guidance of commissural axons, we turned to an *in vitro* system that enables us to measure axon turning in response to guidance cue gradients ([@R56]). We dissected commissural neurons from E13.5 rat spinal cords, electroporated them with either a scrambled shRNA or a shRNA against Arl13b, cultured them for 2 days, and exposed them to a Shh gradient in a Dunn chamber. We imaged the axons and measured changes in trajectory in response to Shh; if the change in trajectory was a positive angle, the axon turned up the Shh gradient, whereas a negative angle indicated an axon turning down the Shh gradient. In commissural neurons electroporated with the scrambled shRNA, we found that axons did not turn significantly in the presence of a BSA control gradient, whereas they turned an average angle of \~30° toward a Shh gradient ([Figures 3G](#F3){ref-type="fig"} and [3H](#F3){ref-type="fig"}). Interestingly, the knock down of Arl13b (using *Arl13b* shRNA) blocked the ability of commissural axons to turn toward Shh. These results indicate that Arl13b is required cell autonomously in commissural neurons for their Shh-dependent guidance response.

Cilia-Localization-Deficient Arl13b Is Sufficient for Shh-Mediated Growth Cone Turning {#S6}
--------------------------------------------------------------------------------------

While we observed that Arl13b is highly enriched in the primary cilium of commissural neurons, we also found Arl13b, albeit at lower levels, present in axons and growth cones of commissural neurons ([Figures 3B](#F3){ref-type="fig"} and [3E](#F3){ref-type="fig"}). The identification of a role for Arl13b in axon guidance, a process taking place at the level of the growth cone, raised the possibility of a novel, non-ciliary function of Arl13b. To directly assess whether the localization of Arl13b to the primary cilium is important for its role in axon guidance, we next used an Arl13b construct harboring a point mutation in the ciliary localization signal (Arl13b^V358A^; [@R23]; [@R36]). While Arl13b-GFP localized strongly to the primary cilium, Arl13b^V358A^-GFP did not localize to the primary cilium but was present in axons and growth cones of commissural neurons ([Figure 4A](#F4){ref-type="fig"}). To test the importance of ciliary localization of Arl13b for axon guidance, we electroporated commissural neurons with either a scrambled shRNA or a shRNA against Arl13b, in the presence or absence of an Arl13b^V358A^ expression plasmid. As expected, neurons electroporated with scrambled shRNA showed attraction toward the Shh gradient ([Figures 4B](#F4){ref-type="fig"}-[4D](#F4){ref-type="fig"}). Knock down of Arl13b abolished the ability of commissural neurons to turn toward Shh. However, when we expressed Arl13b^V358A^ in Arl13b-deficient neurons, we observed that the turning response was completely restored. Together, these results indicate that localization of Arl13b to the primary cilium is not required for its role in axon guidance *in vitro*.

Commissural Axon Projections Are Normal in *Arl13b^V358A/V358A^* Spinal Cord {#S7}
----------------------------------------------------------------------------

To examine the impact of cilia-localization-deficient Arl13b on axon guidance *in vivo*, we generated knockin mice carrying the Arl13b^V358A^ variant ([@R19]). We immunostained forelimb-level E11.5 sections of wild-type and *Arl13b^V358A/V358A^* embryos for the ciliary marker IFT88. Primary cilia were still present in *Arl13b^V358A/V358A^* embryos ([Figure 4E](#F4){ref-type="fig"}). However, despite the Arl13b^V358A^ protein being expressed ([@R19]) and the Arl13b antibody retaining the ability to recognize the Arl13b^V358A^ mutant protein ([Figure S2](#SD1){ref-type="supplementary-material"}), we detected no Arl13b^V358A^ protein in primary cilia ([Figure 4E](#F4){ref-type="fig"}).

We next immunostained wild-type and *Arl13b^V358A/V358A^* embryos with a Robo3 antibody to assess commissural axon trajectory. In E11.5 *Arl13b^V358A/V358A^* embryos, we observed that commissural axons projected to the floor plate in a manner indistinguishable to wild-type embryos ([Figure 4F](#F4){ref-type="fig"}). Indeed, we found no difference in the Robo3 staining area between wild-type and *Arl13b^V358A/V358A^* embryos ([Figure 4G](#F4){ref-type="fig"}), indicating that a cilialocalization-deficient variant of Arl13b is sufficient to mediate commissural axon guidance.

DISCUSSION {#S8}
==========

Our data demonstrate that Arl13b is essential for Shh-dependent commissural axon guidance. Despite cilia being essential to transduce Shh-dependent neural cell fate specification and Arl13b being required for proper trafficking of Shh components within cilia, we found that the role of Arl13b in Shh-dependent axon guidance is cilia localization independent. Thus, Arl13b regulates Shh signaling through two mechanisms: a cilia-associated one to specify cell fate and a cilia-localization-independent one to guide axons.

The *in vivo* axon guidance phenotype that we observed in *Arl13b* mutants has similarities with the phenotype that we have observed in mouse mutants of the Shh axon guidance signaling pathway, such as *Boc* mutants ([@R39]) and *Smo* conditional mutants ([@R10]). The motor column invasion phenotype reflects a defect in long-range commissural axon attraction to the midline. In wild-type conditions, Shh attracts commissural axons over the last few hundred micrometers through the ventral spinal cord, ensuring that the axons' growth is strongly directed to the ventral midline. When Shh attraction is impaired, some axons now invade the motor column and appear to defasciculate from the main axon bundle. Interestingly, the loss of Arl13b impacts commissural axon guidance more severely than the inactivation of *Boc* or the conditional inactivation of *Smo* ([@R10]; [@R39]). Thus, loss of Arl13b has a stronger commissural axon phenotype than loss of Shh-mediated axon guidance alone. This could be due to Arl13b also having---in addition to its cell autonomous role---a non-cell-autonomous role in commissural axon guidance. However, the fact that we do not see the same extent of commissural axon guidance defects in two other mutants (*Tulp3*^−/−^ and *Kif7*^−/−^) harboring neural tube defects similar to *Arl13b* mutants suggests that, on their own, these patterning defects are not sufficient to cause the strong invasion of the motor column observed in *Arl13b* mutants. Nonetheless, we cannot exclude that there might be a relatively minor non-cell-autonomous contribution of Arl13b in commissural axon guidance, in addition to its cell-autonomous role.

Another non-mutually exclusive possibility to explain that loss of Arl13b has a stronger commissural axon phenotype than loss of Shh-mediated axon guidance alone is that Arl13b might be required for other commissural axon guidance cues besides Shh, such as netrin1 or VEGF. In addition to motor column invasion, we also observed that fewer commissural axons reach the ventral midline in *Arl13b* mutants compared to controls. The reason for the reduction in the number of axons reaching the floor plate and thus forming a thinner commissure is unknown. Intriguingly, a reduction in commissure thickness is also observed in a mouse mutant that harbors a floor plate deletion of *netrin1* ([@R53]). Thus, one possibility is that Arl13b is also important for netrin1-mediated axon guidance. Additional work will be required to determine whether this is the case.

Shh in Axon Guidance versus Cell Migration and Cell-type-Specific Roles for Arl13b {#S9}
----------------------------------------------------------------------------------

Shh controls axon guidance by binding the receptor Boc, and possibly Ptch1, which localize to the growth cone ([@R18]; [@R39]). Shh binding elicits two parallel downstream signaling activities: (1) it activates the signal transducer Smo, which in turn activates Src family kinases and initiates a cascade resulting in local actin protein synthesis, and (2) it leads to the polarized activation of cytoskeletal actin remodeling proteins, resulting in growth cone turning toward the Shh source ([@R31]; [@R35]; [@R56]). Because these effects occur locally at the growth cone, independently of Gli-mediated transcription, they are unlikely to require the primary cilium, which is located far back at the cell body. In fact, growth cone turning can take place even if the cell body of the neuron is severed from the axon, indicating that, at least for some guidance cues, this process does not require the cilium to be present ([@R21]). Consistent with this, by expressing the cilia-localization-deficient Arl13b variant *in vitro* and *in vivo*, our data show that Arl13b, despite its robust normal association with the cilium, functions outside the cilium to control axon guidance.

Another Shh-dependent phenomenon that is transcription independent is fibroblast migration in response to Shh. *In vitro*, fibroblasts migrate toward a Shh source, and this is disrupted by mutations in *Ptch1*, *Smo*, or *Arl13b* ([@R5]; [@R36]). Moreover, a cilia-localization-deficient Arl13b variant is not able to support the migration of fibroblasts toward Shh ([@R36]). This contrasts sharply with our results where Arl13b localization to cilia is not required for Shh-mediated commissural axon guidance. One distinction between the two situations is the distance of the primary cilium to the leading edge of migration. In the case of fibroblasts, the primary cilium is very close to the migratory leading edge; however, in neurons, the primary cilium is much further away from the growth cone. Whether this distance plays a role in the requirement for cilium in migration versus guidance remains to be determined. Regardless, this highlights a fundamental difference in the requirement for the localization of Arl13b in cell migration versus axon guidance.

In addition to fibroblasts, Arl13b is also critical for interneuron migration during cortical development ([@R23]). Similar to fibroblast migration in response to Shh, the cilia-localization-deficient Arl13b variant does not rescue Arl13b-deficient interneuron migration. Although Shh affects the motility of interneurons, it remains to be determined whether Shh acts as a guidance cue for these cells ([@R4]). Nonetheless, these results indicate that cell migration and axon guidance have a differential localization requirement for Arl13b.

Do Joubert Syndrome Arl13b Mutants Have Altered Neuronal Localization? {#S10}
----------------------------------------------------------------------

Altered Arl13b subcellular localization might underly the pathological effect of some *Arl13b* mutations in Joubert syndrome. To investigate whether Arl13b mutants that are associated with Joubert syndrome have an altered neuronal localization, we have looked at the three missense Arl13b mutations described so far to be causal for Joubert syndrome ([@R8]; [@R49]). We expressed GFP fusions of Arl13b^WT^, Arl13b^Y86C^, Arl13b^R79Q^, and Arl13b^R200C^ in dissociated commissural neurons ([Figure S3](#SD1){ref-type="supplementary-material"}). Although all of them are expressed in cell lines (data not shown), not all of them are expressed in commissural neurons (Arl13b^Y86C^ and Arl13b^R200C^). In addition, Arl13b^R79Q^, which still localizes to the primary cilium, also localizes abundantly to the growth cone (arrow). Further investigations will be required to assess how this change in localization might impact function.

A Molecular Mechanism for the Axon Guidance Defects of Joubert Syndrome Patients? {#S11}
---------------------------------------------------------------------------------

More than 35 genes have thus far been associated with Joubert syndrome; all of them encode proteins that localize to the cilium or centrosome ([@R13]). The primary diagnostic criterion for Joubert syndrome is the molar tooth sign, a malformation that involves abnormal white matter tracts projecting from the cerebellum. In addition, Joubert syndrome patients display other phenotypes reflecting axon guidance defects, including problems with axonal midline crossing at the pyramidal decussation and the optic chiasm. Because Shh is an axon guidance cue at the optic chiasm ([@R17]; [@R40]), we speculate that the cilia-associated genes mutated in Joubert syndrome might disrupt Shh-mediated axon guidance in addition to disrupting canonical Shh signaling.

In conclusion, our data argue that at least one cilia-associated protein, Arl13b, plays a non-ciliary role in axon guidance. It will be interesting to determine whether the other Joubert-syndrome-associated proteins do the same.

STAR★METHODS {#S12}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S13}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Frédéric Charron (<frederic.charron@ircm.qc.ca>). All unique reagents generated in this study are available from the Lead Contact without restriction.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S14}
--------------------------------------

### Animals {#S15}

All mouse work was performed under the approved guidelines of the Emory University, Yale University Institutional Animal Care and Use Committees, or Canadian Council on Animal Care Guidelines (and approved by the IRCM Animal Care Committee); rat work was performed in accordance with the Canadian Council on Animal Care Guidelines and was approved by the IRCM Animal Care Committee. Staged pregnant Sprague Dawley rats were obtained from Charles River (St. Constant, Canada). Mouse strains used were: *Arl13b^hnn/hnn^* (MGI:3578151), *Arl13b^V358A^* (MGI:6256969, official nomenclature *Arl13b^em1Tc^*)([@R19]), *Kif7* (MGI:4357956, *Kif7tm1.2Hui*) ([@R11]), *Tulp3*^−/−^ (MGI: 5548429 *Tulp3^tm1b(EUCOMM)hmgu^*) ([@R30]). All mouse embryos were used at embryonic day 11.5 (E11.5), as indicated in the [Results](#S2){ref-type="sec"} section and in the figure legends. Rat embryos were used at E13. Male and female embryos were used. Genotyping was performed as previously described for *Arl13b^hnn/hnn^* ([@R9]). *Arl13b^V358A^* PCR genotyping used primers: V358AF -- GAATGAAAAGGAGTCAGCGGG and V358AR -- TGAACCGCTAATGGGA AACT, which yields a \~200 bp wild-type product. The product is cut to 179bp by Cac8I restriction enzyme on the *Arl13b^V358A^* mutant allele.

METHOD DETAILS {#S16}
--------------

### Primary Commissural Neuron Culture {#S17}

Dissociated commissural neuron cultures were prepared as previously described ([@R27]; [@R56]). Briefly, tissue culture plates or acid-washed and sterilized glass coverslips were coated with PLL (100 μg/ml for 2 h). The dorsal fifth of E13 rat neural tubes were microdissected and quickly washed once in cold Ca^2+^/Mg2+-free HBSS. The neural tube sections were trypsinized in 0.15% trypsin in Ca^2+^/Mg2+-free HBSS for 7 min at 37°C. DNase was added for 15 s. The tissue fragments were then washed in warm Ca^2+^/Mg2+-free HBSS and triturated in Ca^2+^/Mg2+-free HBSS to yield a suspension of single cells. Cells were plated in Neurobasal media supplemented with 10% heat-inactivated FBS and 2 mM GlutaMAX. After \~21 h, the medium was changed to Neurobasal supplemented with 2% B27 and 2 mM GlutaMAX. Commissural neurons were used for experiments \~48 h after plating.

### shRNA Generation and Evaluation {#S18}

The target sequence for rat Arl13b was identified using BLOCK-iT™ RNAi Designer (Thermo Fisher Scientific): 5′-TGTGATGGTCGGACTTGATAA --3′.

shRNA target sequence with a microRNA stem (shRNAmir) for knockdown of Arl13b was generated by ligating oligonucleotides encoding the target sequences into the pcDNA6.2-GW/EmGFP-miR vector. The shRNA/miR/EmGFP sequence was then cloned via attB/attP site recombination (using BP clonase) into the pDONR221 backbone (ThermoFisher, 12536-017), and via attL/attR site recombination (using LR clonase) into a custom expression vector derived from Gateway pcDNA-DEST47 (ThermoFisher Scientific, 12281-010). This custom expression vector replaced the promoter and polyA regions of Gateway pcDNA-DEST47 with the promoter and polyA from the pCAGGS vector ([@R48]) to improve its expression in mammalian neurons. The efficiency and specificity of this shRNAs was evaluated *in vitro* by immunofluorescence.

### shRNA-Resistant Arl13b^V358A^ Expression Vectors {#S19}

To perform rescue experiments, we used mouse *Arl13b^V358A^* mutant sequence cloned into the pCAGGS vector for neuronal expression. The mouse sequence is impervious to the rat Arl13b shRNA.

### Arl13b Expression Vectors with Joubert Syndrome Mutations {#S20}

We cloned wild-type Arl13b, Arl13b^Y86C^, Arl13b^R79Q^ and Arl13b^R200C^ into the pCAGGS vector in frame with GFP for neuronal expression.

### Growth Cone Turning Assays {#S21}

Commissural neurons were electroporated with the Amaxa 96-well Shuttle using the Primary Cell 96-well Nucleofector Kit (Lonza, Switzerland) according to the manufacturer's instructions. For each electroporation in one well of a 96-well Nucleofector Plate, 3-5 × 10^5^ cells and 0.6 μg plasmid DNA was used. The electroporation was performed with the program 96-DC-100. In parallel to shArl13b, neurons were treated with a scrambled shRNA control. For Dunn chamber axon guidance assays, primary neurons were grown on PLL-coated square \#3D coverslips (Fisher Scientific) at low density. After Dunn chamber assembly, timelapse phase contrast images were acquired for a minimum of 2 hr. Gradients were generated with 0.1 μg/ml recombinant human Shh, or buffer containing BSA (the vehicle for Shh) as the control in the outer well. The angle turned was defined as the angle between the original direction of the axon and a straight line connecting the base of the growth cone from the first to the last time point of the assay period. For details, see [@R56].

### In Vivo Commissural Axon Staining {#S22}

Immunofluorescence was performed using standard protocols on E11.5 embryonic spinal cords fixed for 1-1/2 hours in 4% PFA in PBS at 4°C, washed 3 times in PBS, then transferred to 30% sucrose in 0.1% phosphate buffer overnight before embedding in OCT and cryosectioning at 14-18 μm. Samples were blocked for 1hr in 10% horse or donkey serum in PBS containing 0.1% Triton X-100. Primary antibodies listed were incubated overnight at 4°C. Anti-Robo3 (1:500, R&D Systems AF3076), anti-Shh (1:20, Developmental Studies Hybridoma Bank, 5E1), rabbit polyclonal anti-Arl13b (1:2000) ([@R9]), anti-Arl13b (1:2000, NeuroMab N295B/66), anti-IFT88 (kind gift from Brad Yoder), and anti-Lhx2 (1:100, Developmental Studies Hybridoma Bank, PCRP-LHX2-1C11). Secondary antibodies were conjugated to Alexa Fluor 488, 568 or 594 (1:1000, Thermo Fisher). Nuclei were visualized with DAPI nuclear dye (1:500, Sigma) added with the secondary antibodies. Sections were mounted in Prolong Gold (Thermo Fisher, P36934) or Mowiol (Calbiochem).

### Imaging and Quantification {#S23}

Images were acquired on Leica SP8 multiphoton confocal microscope. Multiple high-magnification images of the neural tube were taken and stitched using confocal software to form a complete image. Stitched images were false colored and inverted using FIJI.

To quantify the relative Robo3+ area, we measured the neural tube along the ventro-dorsal axis and divided the neural tube into two halves: a dorsal half and a ventral half. We then measured the area occupied by Robo3+ axons relative to the ventral area.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S24}
---------------------------------------

Statistical analyses were performed with GraphPad Prism 5 (La Jolla, CA). Student's t test or Mann-Whitney test were used when there were two groups in the dataset. To compare multiple groups in a dataset, one-way ANOVA was used. The statistical analysis used in each experiment and the definition of n are stated in the figure legends.

DATA AND CODE AVAILABILITY {#S25}
--------------------------

This study did not generate any unique datasets or code.
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![Abnormal Commissural Axon Projections and Midline Crossing in *Arl13b*^*hnn/hnn*^ Spinal Cord\
(A) Schematic of an E11.5 embryo and cross-section of the neural tube at the forelimb level. Sections are labeled with Robo3, which marks commissural axons projecting from the dorsal neural tube to the floor plate.\
(B) Robo3 immunostaining of E11.5 spinal cord cross-sections of *Arl13b*^*hnn/hnn*^ mice.\
(C) The area occupied by Robo3+ axons relative to the total area of the ventral neural tube (mean ± SEM) is significantly higher in *Arl13b*^*hnn/hnn*^ mice compared to control mice (t test, \*\*p \< 0.01).\
(D) Shh immunostaining of E11.5 rostral spinal cord cross-sections. Inset shows the notochord.\
(E) The Shh relative fluorescence intensity is quantified at both rostral and caudal levels (mean ± SEM). Two-way ANOVA, Bonferroni multiple comparisons (\*\*\*\*p \< 0.0001). Number of embryos: 5 *Arl13b*^*hnn/hnn*^; 6 control; and 3 sections per embryo.\
Scale bars: 100 μm (B) and 50 μm (D).\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1546253-f0002){#F1}

![Neural Tube Mispatterning Does Not Cause the Abnormal Commissural Axon Trajectory Observed *Arl13b*^*hnn/hnn*^ Mutants\
(A) IFT88 and Arl13b co-immunostaining of E11.5 spinal cord cross-sections in *Tulp3*^−/−^ and control mice.\
(B) Robo3 immunostaining of E11.5 spinal cord cross-sections of *Tulp3*^−/−^ mice. Some defasciculating axons are noticeable near the floor plate in *Tulp3*^−/−^ mice (arrows).\
(C) Quantification of the area occupied by Robo3+ axons relative to the total area of the ventral neural tube (mean ± SEM) in *Tulp3*^−/−^ mice compared to control mice (t test). Number of embryos: 4 *Tulp3*^−/−^; 3 control; and 2 sections per embryo.\
(D) Robo3 immunostaining of E11.5 *Kif7*^−/−^ spinal cord cross-sections.\
(E) Quantification of the area occupied by Robo3+ axons relative to the total area of the ventral neural tube (mean ± SEM) in *Kif7*^−/−^ compared to *Kif7*^+/−^ mice (t test). Number of embryos: 4 *Kif7*^−/−^ and 3 *Kif7*^+/−^.\
Scale bars: 10 μm (A) and 100 μm (B and D).\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1546253-f0003){#F2}

![Arl13b Is Required for Shh-Mediated Growth Cone Turning\
(A) The mean mRNA expression (fragments per kilobase of exon per million reads \[fpkm\] ± SEM) of *Arl13b, Boc,* and *Smo* in dissociated commissural neurons (n = 3 independent experiments).\
(B) Arl13b and acetylated tubulin immunostaining of dissociated commissural neurons. Arl13b is highly enriched at the primary cilium (zoom-in, B1) and present in the growth cone (zoom-in, B2).\
(C) Arl13b immunostaining of neurons electroporated with scrambled shRNA or shRNA against Arl13b (shArl13b). Electroporated neurons were monitored by GFP expression.\
(D) Quantification of the percentage of electroporated (GFP+) cells showing an Arl13b+ cilium (±SEM) compared to scrambled (Mann-Whitney test) (80 cells for scrambled and 77 cells for shArl13b).\
(E) When shArl13b is electroporated in commissural neurons, the growth cone Arl13b staining is highly reduced.\
(F) Quantification of Arl13b mean fluorescence in the growth cone (± SEM) compared to scrambled (Mann-Whitney test, n = 3 independent experiments).\
(G) Rose histograms of the distribution of angles turned by commissural axons expressing either scrambled shRNA or shArl13b in Dunn chambers, exposed to a gradient of Shh (0.1 μg/ml) or BSA. Responses of individual neurons were clustered in 15° bins, and the number of neurons per bin is represented by the radius of each segment.\
(H) Quantification of the angle turned (mean ± SEM) (one-way ANOVA, Dunnett's multiple comparison post-test, \*p \< 0.05, n \> 30 neurons per condition).\
Scale bars: 10 μm (B), 20 μm (C), and 5 μm (E).](nihms-1546253-f0004){#F3}

![Cilia-Localization-Deficient Arl13b Is Sufficient for Shh-Mediated Growth Cone Turning *In Vitro* and Commissural Axon Guidance *In Vivo*\
(A) Arl13b-GFP or Arl13b^V358A^-GFP localization in commissural neurons. Arrows: primary cilia. Arrowheads: growth cones.\
(B) Commissural neurons expressing scrambled shRNA, shArl13b, or shArl13b + cilia-localization-deficient Arl13b (V358A) exposed to a gradient of Shh (0.1 μg/ml) or BSA.\
(C and D) Rose histograms (C) or standard histogram (D) of the angle turned (mean ± SEM) (one-way ANOVA, Tukey's multiple comparison post-test, \*\*p \< 0.01, n \> 30 neurons per condition).\
(E) IFT88 and Arl13b co-immunostaining of E11.5 spinal cord cross-sections of *Arl13b^V358A/V358A^* mice compared to control mice.\
(F) Robo3 immunostaining of E11.5 spinal cord cross-sections of *Arl13b^V358A/V358A^* mice compared to control mice.\
(G) Quantification of the area occupied by Robo3+ axons relative to the total area of the ventral neural tube (mean ± SEM) (t test). Number of embryos: 4 *Arl13b^V358A/V358A^*; 4 control; and 2 sections per embryo.\
Scale bars: 20 μm (A), 10 μm (B and E), and 200 μm (F).\
See also [Figures S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"}.](nihms-1546253-f0005){#F4}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                              SOURCE                                 IDENTIFIER
  -------------------------------------------------------------------------------- -------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
  Antibodies                                                                                                              
  Goat polyclonal anti-Robo3 (1:500 for IF)                                        R&D Systems                            Cat\#: AF3076; RRID: AB_2181865
  Mouse anti-Shh 5E1 (1:20 for IF)                                                 Developmental Studies Hybridoma Bank   Cat\#: 5E1; RRID:AB_528466
  Rabbit polyclonal anti-Arl13b (1:2000 for IF)                                    [@R9]                                  N/A
  Mouse anti-Arl13b (1:2000 for IF)                                                NeuroMab                               Cat\# N295B/66; RRID:AB_2750771
  Rabbit polyclonal anti-IFT88 (1:1000)                                            kind gift from Brad Yoder              N/A
  Mouse anti-Lhx2 (1:100 for IF)                                                   Developmental Studies Hybridoma Bank   PCRP-LHX2-1C11; RRID:AB_2618817
  Donkey anti-goat IgG Cy3 (1:500)                                                 Jackson ImmunoResearch Laboratory      Cat\#: 705-165-147; RRID: AB_2307351
  Secondary antibodies were conjugated to Alexa Fluor 488, 568 or 594 (1:1000).    Thermo Fisher                          Cat\#: A21202; RRID:AB_141607, A10037; RRID:AB_2534013, A21206; RRID:AB_2535792, A21207; RRID:AB_141637
  Bacterial and Virus Strains                                                                                             
  DH5a                                                                             Life Technologies                      Cat\#: 18265-017
  *ccd*B                                                                           Thermo Fisher                          Cat\#: A10460
  HB101                                                                            Promega                                Cat\#: L2011
  Chemicals, Peptides, and Recombinant Proteins                                                                           
  Recombinant Human Sonic Hedgehog (C24II) N terminus                              R&D Systems                            Cat\#: 1845-SH
  Bovine serum albumin (BSA)                                                       MultiCell                              500-0206
  Poly-L-lysine solution (molecular weight 70,000-150,000, concentration: 0.01%)   Sigma-Aldrich                          P4707
  DAPI                                                                             Sigma-Aldrich                          Cat\# D9564
  Critical Commercial Assays                                                                                              
  Primary Cell 96-well Nucleofector Kit                                            Lonza                                  Cat \#: V4SP-3960
  Experimental Models: Organisms/Strains                                                                                  
  Rat: ARS/Sprague Dawley                                                          Charles River (St. Constant, Canada)   N/A
  *Arl13b^hennin^*                                                                 [@R9]                                  MGI:3578151
  *Tulp3^tm1b(EUCOMM)hmgu^*                                                        [@R30]                                 MGI: 5548429
  *Kif7*                                                                           [@R11]                                 MGI:4357956
  *Arl13b^V358A^*                                                                  [@R19]                                 MGI:6256969
  Recombinant DNA                                                                                                         
  pcDNA6.2-GW/EmGFP-miR                                                            Invitrogen                             K493600
  pCAGGs-mouse Arl13b-GFP                                                          This article                           N/A
  pDONR221                                                                         ThermoFisher                           12536-017
  pcDNA-DEST47                                                                     ThermoFisher                           12281-010
  pCAGGS                                                                           [@R48]                                 N/A
  pCAGGS-Arl13b^Y86C^-GFP                                                          This article                           N/A
  pCAGGS-Arl13b^R79Q^-GFP                                                          This article                           N/A
  pCAGGS-Arl13b^R200C^-GFP                                                         This article                           N/A
  Software and Algorithms                                                                                                 
  Prism 7 for Mac OS X                                                             Graphpad                               [https://download.cnet.com/GraphPad-Prism/3000-2053_4-8453.html](https://download.cnet.com/GraphPad-Prism/3000-2053_4-8453.html/)
  ImageJ                                                                           NIH                                    <https://imagej.nih.gov/ij/>
  BLOCK-iT\_ RNAi Designer                                                         ThermoFisher Scientific                <https://rnaidesigner.thermofisher.com/rnaiexpress/>
  Illustrator CC                                                                   Adobe                                  <http://www.adobe.com/jp/products/illustrator.html>
  Photoshop CC                                                                     Adobe                                  <https://www.adobe.com/products/photoshop.html>
  Other                                                                                                                   
  Dunn Chamber                                                                     Hawksley                               DC-100

###### Highlights

-   *Arl13b* null mutant mice display commissural axon guidance defects

-   Arl13b is required for Shh-mediated growth cone attraction

-   Cilia-deficient Arl13b is sufficient for its role in axon guidance
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